Roche vet James Sabry departs—Chutes & Ladders fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.
FDA delays decision on Dupixent in COPD; Summit makes a bold claim biopharmadive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biopharmadive.com Daily Mail and Mail on Sunday newspapers.
(Reuters) - Neurocrine Biosciences CEO Kevin Gorman will retire on Oct. 11 after three decades with the company that he founded and will be succeeded by insider Kyle Gano. Gorman founded Neurocrine in 1992 and held several leadership positions befo.
Latest health news includes Louisiana's reclassification of abortion pills as controlled substances, the effectiveness of bird flu vaccines in laying hens, and rising forecasts for weight-loss drug sales. Other updates cover M&A deals, CEO retirements, Neuralink's brain implant study, and WHO's push for pandemic response rules.